Early Detection and Integrated Care for Adolescents and Young Adults with Psychotic Disorders: the ACCESS III Study
Overview
Authors
Affiliations
Objective: The objective of the study was to investigate whether a combined intervention composed of early detection plus integrated care (EDIC) enhances outcomes in patients with early psychosis compared to standard care (SC).
Methods: ACCESS III is a prospective non-randomized historical control design 1-year study examining the efficacy of EDIC (n = 120) vs. SC (n = 105) in patients aged 12-29 years. Primary outcome was the rate of ≥6 months combined symptomatic and functional remission. Additional outcomes comprised the reduction of DUP and course of psychopathology, functioning, quality of life, and satisfaction with care.
Results: In observed cases, 48.9% in the EDIC and 15.2% in the SC group reached the primary endpoint. Remission was predicted by EDIC (OR = 6.8, CI: 3.15-14.53, P < 0.001); younger age predicted non-remission (OR = 1.1, CI: 1.01-1.19, P = 0.038). Linear regressions indicated a reduction of DUP in EDIC (P < 0.001), but not in SC (P = 0.41). MMRMs showed significantly larger improvements in PANSS positive (P < 0.001) and GAF (P < 0.01) scores in EDIC vs. SC, and in EDIC over time in CGI-Severity (P < 0.001) and numerically in Q-LES-Q-18 (P = 0.052).
Conclusions: EDIC lead to significantly higher proportions of patients achieving combined remission. Moderating variables included a reduction of DUP and EDIC, offering psychotherapeutic interventions.
Bernhardt M, Siebert S, Baumgardt J, Domanska O, Leopold K, Bechdolf A Nervenarzt. 2025; 96(1):50-56.
PMID: 39821674 PMC: 11772393. DOI: 10.1007/s00115-024-01777-4.
Salazar de Pablo G, Guinart D, Armendariz A, Aymerich C, Catalan A, Alameda L Schizophr Bull. 2024; 50(4):771-783.
PMID: 38491933 PMC: 11283197. DOI: 10.1093/schbul/sbae017.
Rohenkohl A, Sowada P, Lambert M, Gallinat J, Karow A, Ludecke D Front Psychol. 2024; 14:1285575.
PMID: 38192398 PMC: 10773616. DOI: 10.3389/fpsyg.2023.1285575.
Ruhl F, Lambert M, Rohenkohl A, Kraft V, Daubmann A, Schneider B Front Psychol. 2024; 14:1237718.
PMID: 38187418 PMC: 10768197. DOI: 10.3389/fpsyg.2023.1237718.
Schroter R, Lambert M, Rohenkohl A, Kraft V, Ruhl F, Luedecke D Eur Psychiatry. 2022; 66(1):e1.
PMID: 36329654 PMC: 9879911. DOI: 10.1192/j.eurpsy.2022.2332.